XAGEWNCM

Longevity Health Holdings, Inc.

$0.01

-0.00 (-1.96%)

News

No News Yet

Press releases and SEC filings for XAGEW will appear here as they are published.

Check back later for updates

Key Data

Market Cap—

Open$0.01

Prev Close$0.01

Day Range$0.01 – $0.01

52W Range$0.01 – $0.01

Volume16,099

P/E (TTM)—

EPS—

Dividend Yield—

Beta0.28

Revenue Growth2606.00%

About

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

www.carmellcosmetics.com

Top Institutional Holders

As of 2025-12-31 · prior 2025-09-30

CARNEGIE MELLON UNIVERSITY$1,349

4,472 sh-0.2%

See all holders →

Quarterly Financials

09/25

Revenue Net Income